Rottenstein Law Group Notes Request for Physician Participation in Registry to Track Use of Risperdal and Other Atypical Antipsychotic Drugs by Pregnant Women
The Rottenstein Law Group LLP, a national personal injury law firm which maintains a Risperdal lawsuit informational web site at www.risperdallawsuit.us, notes the call for physician participation by researchers who are compiling a registry of the use of atypical antipsychotic medications like Risperdal by pregnant women. The researchers are attempting to establish a link between the drugs and birth defects, as the use of these medications by pregnant women is increasing.
View full press release